Navigation Links
Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development
Date:1/31/2008

sion-makers and encourage them to allocate resources to Parkinson's projects. To date, of the approximately $21 million the Foundation has committed in total funding to industry, almost a third (nearly $8 million) has gone to 14 projects under TDI. The current round of awardees will focus on developing and optimizing new treatments targeting alpha-synuclein toxicity; chronic inflammation; trophic factors; and mitochondrial dysfunction.

Christine Bulawa, PhD, of FoldRx Pharmaceuticals Inc., will work to develop a disease-modifying drug that could block the toxicity associated with clumping of the protein alpha-synuclein, a hallmark of PD pathology. Dr. Bulawa's team has identified chemical compounds that protect neurons from alpha-synuclein toxicity and will now work with the compounds in a rodent model of Parkinson's. The researchers hope to identify promising small molecules that, with further optimization, can be developed into drug candidates to be tested in PD patients in clinical trials.

Chronic inflammation plays a role in the death of the dopamine-producing neurons that are lost in Parkinson's disease. Patrick Flood, PhD, of TheraLogics, Inc., and his group will test compounds that specifically target the inflammatory pathway in a PD animal model to determine whether certain drugs can protect against this neuronal loss. The team will assess whether blocking inflammation reverses destruction of dopamine-producing neurons, and actually leads to regeneration of these cells within the brain, to determine the most effective dose and timing for therapeutic intervention.

The blood-brain barrier is a thin layer of tightly packed cells separating the central nervous system from the body's bloodstream. This layer is crucial to protecting the brain from foreign substances, but also poses a major challenge in delivering potentially therapeutic treatments via orally administered drugs. Antonia Orsi, PhD, and her team from Phytopharm have develop
'/>"/>

SOURCE Michael J. Fox Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Kevin McHale Instrumental in Forming the Help Me Hear Foundation
2. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
3. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
4. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
5. The Oral Cancer Foundation Urges HPV Vaccination for Males
6. MedicAlert Foundation Joins The Alzheimers Association to Offer MedicAlert(R) + Alzheimers Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies
7. Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium
8. Grantees of the Avon Foundation Breast Cancer Prevention Research Initiative Gather in Houston to Report Interim Findings
9. Five Clinical Studies to Receive $2.5 Million Under Foundations 2007 Clinical Discovery Program
10. Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1
11. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 7, 2015   Bionik Laboratories Corp. ... with a core focus in robotic exoskeleton technology ... "Company"), announced today that it has completed an ... consisting of its common stock and warrants for ... a private placement transaction.  This equity financing is ...
(Date:7/7/2015)... Oasmia Pharmaceutical AB, a ... human and veterinary oncology, today announced that it ... the United States , designed to generate ... therapeutic.      (Logo: http://photos.prnewswire.com/prnh/20150420/740096) , ... Paccal Vet-CA1 was previously distributed by ...
(Date:7/7/2015)...  Monopar Therapeutics LLC, an emerging biopharmaceutical company focusing ... and CEO, Chandler D. Robinson MD, MBA, ... Award. The British Council selected one recipient from each ... , and the United States ... who have leveraged their U.K. education in their subsequent ...
Breaking Medicine Technology:Bionik Laboratories Completes US$13.1 Million Private Placement 2Bionik Laboratories Completes US$13.1 Million Private Placement 3Oasmia Pharmaceutical Launches US Brand and Sales Platform 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 3
... pharmaceutical and medical device companies evolve, market research ... refining current ones to support intelligent planning and ... beginning to explore different types of technological advances ... external data collection and internal asset creation. ...
... 2012   CareFusion Corp. (NYSE: CFN ... that its board of directors authorized the repurchase of ... (Logo:  http://photos.prnewswire.com/prnh/20100706/CAREFUSIONLOGO ) "This ... potential and our commitment to increasing shareholder value," said ...
Cached Medicine Technology:Pharmaceutical Industry Leveraging New Tools to Overcome Challenges in Market Research 2CareFusion Announces $500 Million Share Repurchase Program 2CareFusion Announces $500 Million Share Repurchase Program 3
(Date:7/7/2015)... , ... July 07, 2015 , ... ... highlights rumors about possible facial rejuvenation that have emerged about Hillary Clinton. Two ... Secretary of State looks more youthful than she has in some time and ...
(Date:7/7/2015)... NY (PRWEB) , ... July 07, 2015 , ... ... email newsletter and website that helps active people find the most fun activities to ... active lifestyle coverage for millennials. It also increases Greatist’s opportunity for events, e-commerce, and ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... group whose board is limited to permit holders. The Medical Cannabis Alliance of ... move the industry forward and are committed to making sure patients have access ...
(Date:7/7/2015)... ... ... end of June Pacific Prime Renewals team in Hong Kong announced that they were ... Manager, Danielle Cotton, aims to not only reduce but eventually eliminate the use of paper ... anything between 300 and 600 pieces of paper per month. Not to mention A4 sized ...
(Date:7/7/2015)... ... July 07, 2015 , ... The Immune Deficiency Foundation ... patient community using its IDF ePHR, an electronic personal health record powered by ... to easily track their health information, including symptoms, diagnoses, medications, infusions and other ...
Breaking Medicine News(10 mins):Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3
... 13, 2007 Schizophrenia is one of the most debilitating ... the most difficult to treat. Although numerous antipsychotic treatments ... patients experience only a partial relief of their symptoms and ... new study scheduled for publication in the December 15th issue ...
... to achieving financial ... success, ... that it was launching "The Power of Deliberate Creation," a,two-disc set and ... in a 7 step process. According to,inspirational author and financial success "guru" ...
... 13 Naviscan PET Systems(R), a,privately held company specializing ... Antonio Breast Cancer Symposium -- new clinical,data from a ... management., PEM Flex(TM) Solo II is a commercially ... small body parts such as the,breast and hand. Solo ...
... Phase II Study of Ofatumumab in Relapsed ... Diffuse Large B-Cell Lymphoma, COPENHAGEN, ... centers have been initiated and are,ready to enroll patients in a ... Large B-Cell Lymphoma (DLBCL) in,patients ineligible for or relapsed following a ...
... Dec. 13 ,GlaxoSmithKline (GSK) plc today presented an overview of its neuroscience,portfolio and ... York., ... Highlights, -- Innovative neuroscience pipeline ... schizophrenia, and multiple sclerosis (MS): ...
... U.S. Preventive Medicine(R),a company that is building ... the,United States and internationally ( http://www.USPreventiveMedicine.com ),announced ... intent with iHealth UK Ltd. to,jointly develop ... Kingdom.,iHealth brings together leading clinicians, advanced modalities, ...
Cached Medicine News:Health News:Effective new treatment for schizophrenia 2Health News:John Alexandrov Reveals 'the Secret' to Financial Success Via Launch of 'The Power of Deliberate Creation' Audio CDs 2Health News:John Alexandrov Reveals 'the Secret' to Financial Success Via Launch of 'The Power of Deliberate Creation' Audio CDs 3Health News:Naviscan's PEM Flex(TM) Scanner Shows Promising New Data in Breast Cancer Management 2Health News:Genmab Initiates Ofatumumab Phase II Study in Diffuse Large B-Cell Lymphoma 2Health News:Genmab Initiates Ofatumumab Phase II Study in Diffuse Large B-Cell Lymphoma 3Health News:GlaxoSmithKline Presents Innovative Neuroscience Pipeline 2Health News:GlaxoSmithKline Presents Innovative Neuroscience Pipeline 3Health News:GlaxoSmithKline Presents Innovative Neuroscience Pipeline 4Health News:GlaxoSmithKline Presents Innovative Neuroscience Pipeline 5Health News:GlaxoSmithKline Presents Innovative Neuroscience Pipeline 6Health News:GlaxoSmithKline Presents Innovative Neuroscience Pipeline 7Health News:GlaxoSmithKline Presents Innovative Neuroscience Pipeline 8Health News:U.S. Preventive Medicine to Expand into England with iHealth UK Ltd. 2Health News:U.S. Preventive Medicine to Expand into England with iHealth UK Ltd. 3
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: